Alto Neuroscience
ANRO
ANRO
83 hedge funds and large institutions have $45M invested in Alto Neuroscience in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 18 increasing their positions, 27 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
21% less call options, than puts
Call options by funds: $50K | Put options by funds: $63K
33% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 27
53% less capital invested
Capital invested by funds: $95.3M → $45M (-$50.3M)
Holders
83
Holding in Top 10
2
Calls
$50K
Puts
$63K
Top Buyers
| 1 | +$2.05M | |
| 2 | +$463K | |
| 3 | +$233K | |
| 4 |
IHAM
Integral Health Asset Management
New York
|
+$216K |
| 5 |
SCM
SCS Capital Management
Boston,
Massachusetts
|
+$144K |
Top Sellers
| 1 | -$1.72M | |
| 2 | -$1.03M | |
| 3 | -$977K | |
| 4 |
CF
Cantor Fitzgerald
New York
|
-$724K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$566K |
